The latest news and stats on sleep apnea, COPD, and out-of-hospital care from
ResMed, a world-leading connected health company. 

Tubes up! AirFit P30i, N30i help nasal and nasal pillows wearers sleep better in any position

Read the AirFit P30i press release

Tubes up! AirFit P30i, N30i help nasal and nasal pillows wearers sleep better in any position

Read the AirFit P30i press release

Latest news

Latest news

May 23, 2019

SAN DIEGO -- May 23, 2019, ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 39th Annual William Blair Growth Stock Conference on...

May 20, 2019

DALLAS, May 21, 2019 – Remote monitoring and patient self-monitoring can drive CPAP adherence for people with sleep apnea, according to research presented by ResMed (NYSE: RMD, ASX: RMD) at the...

May 19, 2019

DALLAS, May 19, 2019 – ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors affect adherence to PAP (positive airway pressure) therapy, according to a study it...

See all news releases

Fast facts - Landing Page

Fast facts

  • +1.8 MILLION
    myAir users self-monitor their CPAP treatment
  • +9 MILLION
    100% cloud connectable devices worldwide
  • +14 MILLION
    lives changed by a ResMed device, mask, or accessory

See all fast facts

In the news

In the news

May 23, 2019
KSTP-TV Minneapolis
A clinical trial through the Minnesota Lung Center is investigating how portable oxygen much smaller in size than traditional tanks can keep people more active.
May 17, 2019
India Times
A big challenge in India is to spend time educating physicians, government and also educating people, who have sleep apnoea and COPD but don't know how they can adequately treat them.
April 26, 2019
One example was provided by Bobby Ghoshal, chief technology officer of ResMed. Users of ResMed’s sleep apnea device often have comorbid conditions such as diabetes, congestive heart failure or cancer. With more than 6 million devices around the world producing data on 3.5 billion nights of sleep, “you can take our data set and do a longitudinal study and see how treatment of sleep apnea affects the other comorbidities,” said Ghoshal, thereby opening up opportunities for interventions to prevent those conditions worsening.

See all articles

Infographics - Landing Page


Learn about respiratory conditions, their effects on our health and communities,
and how ResMed helps millions live and breathe better.


See all infographics

Media resources - Gray, Left - Landing Page

Media resources

Find everything you need.
Ask us for more information.

See all resources

Media contacts - Gray, Right - Landing Page

Media contact

Jayme Rubenstein
(858) 836-6798


Email Alerts - Landing Page

Sign up to receive ResMed news releases when they publish.



ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages